<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Clopidogrel after percutaneous coronary intervention</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Clopidogrel after percutaneous coronary intervention</h1>
<div class="graphic"><div class="figure"><div class="ttl">Clopidogrel after percutaneous coronary intervention</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Data from the CREDO trial of more than 2100 patients undergoing elective percutaneous coronary intervention, almost all with stenting, who were treated with a loading dose of clopidogrel or placebo before the procedure and then clopidogrel for 28 days; clopidogrel or placebo, according to original randomization, was then given for the remainder of one year. The combined end point of death, myocardial infarction, or stroke at one year occurred significantly less often in those treated with clopidogrel (relative risk reduction 26.9 percent, 95% CI 3.9-44.4 percent).</div><div class="graphic_reference">Data from Steinhubl SR, Berger PB, Mann JT 3rd, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 2002; 288:2411.</div><div id="graphicVersion">Graphic 80138 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
